Label:
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE- clindamycin phosphate and benzoyl...
view full title

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated April 30, 2024

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    1.1 Indication - Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% is indicated for the topical treatment of inflammatory acne vulgaris in patients 12 years and older. 1.2 Limitations ...
  • 2 DOSAGE AND ADMINISTRATION
    Apply a thin layer of Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% to the face once daily, in the evening or as directed by the physician. The skin should be gently washed, rinsed with ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Gel, 1.2%/5% Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% is a white to slightly yellow, opaque gel. Each gram of Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% contains 12 mg ...
  • 4 CONTRAINDICATIONS
    4.1 Hypersensitivity - Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any ...
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Colitis - Systemic absorption of clindamycin has been demonstrated following topical use of clindamycin. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been ...
  • 6 ADVERSE REACTIONS
    The following adverse reaction is described in more detail in the - Warnings and Precautions section of the label: Colitis - [see Warnings and Precautions ...
  • 7 DRUG INTERACTIONS
    7.1 Erythromycin - Avoid using Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% in combination with erythromycin-containing products due to its clindamycin component. In vitro studies have ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women treated with Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin ...
  • 11 DESCRIPTION
    Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% is a fixed combination product with two active ingredients in a white to slightly yellow, opaque, aqueous gel formulation. Clindamycin ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Clindamycin - Clindamycin is a lincosamide antibacterial - [see Clinical Pharmacology ( 12.4)]. Benzoyl Peroxide - Benzoyl ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment Of Fertility - Benzoyl peroxide has been shown to be a tumor promoter and progression agent in a number of animal studies. Benzoyl peroxide in acetone ...
  • 14 CLINICAL STUDIES
    In five randomized, double-blind clinical trials of 1,319 subjects, 397 used Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 396 used benzoyl peroxide, 349 used clindamycin, and 177 used ...
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    16.1 How Supplied - Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% is a white to slightly yellow, opaque gel. NDC: 72162-2299-2: 45 g in a TUBE - 16.2 Storage and Handling - Pharmacist: Prior ...
  • 17 PATIENT COUNSELING INFORMATION
    Advise the patient to read the FDA-approved patient labeling (Patient Information). Patients who develop allergic reactions such as severe swelling or shortness of breath should discontinue use ...
  • PATIENT INFORMATION
    PHARMACIST – DETACH HERE AND GIVE INSTRUCTIONS TO PATIENT - PATIENT INFORMATION - Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% Important: For use on the skin only (topical use) ...
  • PRINCIPAL DISPLAY PANEL
    Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% Extended Label
  • INGREDIENTS AND APPEARANCE
    Product Information